摘要
背景:骨肉瘤(OS)是一种以年轻人为主的肿瘤性疾病,它通常发生在骨生长的区域,肿瘤细胞在晚期呼吸衰竭时转移到肺部。硒。这种疾病没有真正的治疗方法,常规药物会产生副作用,从而降低患者的生活质量。需要新的、更安全的药物,一种途径是使用纳豆。能够阻碍肿瘤生长的铝化合物。 目的:对磷虾油和鱼油这两种生物实体进行评价。在长达72h的时间过程中,将人OS细胞暴露于磷虾油、鱼油、EPA和DHA中。 结果:磷虾油在24、48和72h分别抑制了23、50和64%的细胞增殖,而鱼油在24、48和72小时内无显著变化。 泰雷西汀Gly、EPA和DHA促进了该肿瘤细胞的增殖和迁移。磷虾油对OS的抑制作用与临床常用药物阿霉素0.5和1μ相似。 结论:磷虾油可与标准的临床应用相结合,控制原发性肿瘤的生长,更重要的是控制肿瘤的转移。
关键词: 癌症,DHA,EPA,鱼油,磷虾油,骨肉瘤。
图形摘要
Current Drug Targets
Title:The Effect of Krill Oil and n-3 Polyunsaturated Fatty Acids on Human Osteosarcoma Cell Proliferation and Migration
Volume: 19 Issue: 5
关键词: 癌症,DHA,EPA,鱼油,磷虾油,骨肉瘤。
摘要: Background: Osteosarcoma (OS) is a neoplastic condition afflicting mostly the young, as the lesion usually occurs in areas of bone growth with tumour cells metastasising to the lungs in advanced disease. There is no real cure for the disease, with conventional drugs causing side-effects that decrease the quality of life of sufferers. Newer and safer drugs are needed, and one avenue is to use natural compounds that can stunt the growth of the tumour.
Objective: In this study, two such biological entities were evaluated: krill oil and fish oil. Human OS cells were exposed to krill oil, fish oil, EPA and DHA in time-course assays lasting up to 72h.
Results: Krill oil inhibited 23, 50 and 64% of cell proliferation at 24, 48 and 72h respectively, while fish oil resulted in no significant changes although an increase was observed at 24h. Interestingly EPA and DHA promoted OS cell proliferation and migration in this neoplasia. The inhibitory effect of krill oil was comparable to 0.5 and 1µM doxorubicin, a commonly used clinical drug for OS treatment.
Conclusion: These results indicate that krill oil may be used in combination with standard clinical practices to control primary tumour growth, and more importantly, metastasis.
Export Options
About this article
Cite this article as:
The Effect of Krill Oil and n-3 Polyunsaturated Fatty Acids on Human Osteosarcoma Cell Proliferation and Migration, Current Drug Targets 2018; 19 (5) . https://dx.doi.org/10.2174/1389450116666150107152206
DOI https://dx.doi.org/10.2174/1389450116666150107152206 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
NAD<sup>+</sup>/NADH Metabolism and NAD<sup>+</sup>-Dependent Enzymes in Cell Death and Ischemic Brain Injury: Current Advances and Therapeutic Implications
Current Medicinal Chemistry Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer
Current Neurovascular Research The DREAM of Pain Relief
Current Rheumatology Reviews Pharmacologic Activation of p53 by Small-Molecule MDM2 Antagonists
Current Pharmaceutical Design p38 MAPK: A Potential Target of Chronic Pain
Current Medicinal Chemistry Moving Beyond VEGF for Anti-angiogenesis Strategies in Gynecologic Cancer
Current Pharmaceutical Design Therapeutic Transfer of DNA Encoding Adenoviral E1A
Recent Patents on Anti-Cancer Drug Discovery iPSCs Derived from Malignant Tumor Cells: Potential Application for Cancer Research
Current Stem Cell Research & Therapy Are the Antioxidant Properties of Carvedilol Important for the Protection of Cardiac Mitochondria?
Current Vascular Pharmacology Inhibition of Pigment Epithelium-Derived Factor (PEDF) Augments Vascular Endothelial Growth Factor (VEGF)-Induced Recovery of Limb Perfusion after Ischemia in Klotho Mouse
Letters in Drug Design & Discovery ErbB4 and its Isoforms: Patentable Drug Targets?
Recent Patents on DNA & Gene Sequences Carvacrol Suppresses Human Osteosarcoma Cells via the Wnt/β-Catenin Signaling Pathway
Anti-Cancer Agents in Medicinal Chemistry Transductional and Transcriptional Targeting of Adenovirus for Clinical Applications
Current Gene Therapy Dextran-based Nanocarriers for Delivery of Bioactives
Current Pharmaceutical Design Regulation of Tumor Angiogenesis by the Immune System
Current Angiogenesis (Discontinued) The Tumor Suppressor Gene ARF as a Sensor of Oxidative Stress
Current Molecular Medicine Multimodality Imaging of RNA Interference
Current Medicinal Chemistry Bone Marrow Concentrate: A Novel Strategy for Bone Defect Treatment
Current Stem Cell Research & Therapy Phosphodiesterase 3 (PDE3): Structure, Localization and Function
Cardiovascular & Hematological Agents in Medicinal Chemistry RUNX2 and Osteosarcoma
Anti-Cancer Agents in Medicinal Chemistry